Yaya yawan cututtukan COVID-19 ke faruwa bayan allurar?
Fara rigakafin COVID-19 Tambayoyin da ake yawan yi A ina zan iya yin allurar? Bincika ko za ku iya yin rigakafin

Mutanen da aka yi wa rigakafin COVID-19 suma suna iya kamuwa da cutar ta coronavirus, kodayake wannan ba kasafai ba ne. Har ila yau, an yi nufin rigakafin ne don hana mummunan yanayin cutar, haɗarin asibiti da mutuwa. A wannan yanayin, allurar rigakafi suna nuna tasiri sama da 90%. Ka tuna - yawan mutanen da aka yi wa alurar riga kafi, mafi girman tasirin rigakafin.

  1. Babu maganin rigakafi da zai iya kare kashi 19% na kamuwa da cutar COVID-100. Duk da haka, yana rage haɗarin cututtuka sosai
  2. Alurar riga kafi sun fi tasiri wajen kariya daga kamuwa da cuta mai tsanani, wajabcin asibiti da haɗarin mutuwa.
  3. An tabbatar da hakan ta hanyar wani bincike da kwararrun Amurkawa suka buga kwanan nan
  4. Ana iya samun ƙarin bayani na yanzu akan shafin farko na Onet.

COVID-19 bayan alurar riga kafi? Yana yiwuwa

Wannan ba sabon abu ba ne - kwararru suna tunatar da cewa babu wani maganin da zai sami kashi 100. tasiri. Duk da haka, kowane maganin rigakafi, da za a ba da izini don amfani, dole ne ya cika buƙatun da suka dace: dole ne ya kasance yana da kyakkyawan bayanin tsaro, ya zama mai jurewa da masu karɓa, dole ne ya zama rigakafi, watau haifar da amsawar tsarin rigakafi, kuma dole ne ya dace da abin da ake bukata. tasiri.

- Dukkanin allurar rigakafin COVID-19 da aka amince da su (ciki har da AstraZeneka) suna ba da babban matakin kariya daga mafi tsananin yanayin COVID-19. Nazarin asibiti ya nuna cewa suna da kusan kashi 100. tasiri a cikin rigakafin asibiti, idan mutumin da aka yi wa allurar ya kamu da cutar ta coronavirus - ya jaddada Dr. Piotr Rzymski, kwararre a fannin ilimin halittu da bincike a Jami'ar Kiwon Lafiya ta Karol Marcinkowski a Poznań.

"A cikin manyan bazuwar, gwaje-gwaje na asibiti makafi biyu (irin wannan dabarar tana ba da tabbacin mafi ingancin binciken da ingantaccen sakamako), an nuna kowane allurar rigakafi yana da aminci kuma yana da tasiri wajen hana alamun bayyanar cututtuka da gwajin gwajin gwajin COVID-19. Duk da babban matakin tasirin rigakafin, ƙaramin adadin mutanen da ke da cikakken rigakafin za su haɓaka asymptomatic ko kamuwa da cuta ta SARS-CoV-2, a cewar wata takarda da CDC ta buga, Cibiyar Kariya da Kula da Cututtuka ta Amurka.

Wasu abubuwan lura sun nuna cewa a matsakaita, lokuta na rashin lafiya bayan allurar rigakafin COVID-19 suna faruwa a ƙasa da kashi 5% na masu amsawa. mutane. Daga cikinsu akwai, ko da yake ba a cika yin amfani da su ba, har ma da wasu lokuta masu mutuwa.

Binciken cututtukan cututtuka bayan cikakken rigakafin a cikin lokacin daga Janairu 1 zuwa Afrilu 30, 2021 kwanan nan masana kimiyya daga CDC ne suka yi, waɗanda ke sa ido kan lamarin a kan ci gaba.

Mutane nawa ne cikakken alurar riga kafi suka sami COVID-19?

Ya zuwa wannan ranar, kusan mutane miliyan 101 a Amurka sun sami cikakkiyar rigakafin cutar ta COVID-19.

"Har zuwa 30 ga Afrilu, jihohi 46 sun yi rajistar jimlar 10 na kamuwa da cutar SARS-CoV-262 a cikin wannan rukunin (cikakken rigakafin). Daga cikin su, 6 (446%) ya faru a cikin mata, kuma matsakaicin shekarun mai haƙuri shine shekaru 63. An ƙaddara da farko cewa 58 (2%) cututtuka bayan cikakken allurar rigakafi ba su da lafiya, 725 (27%) marasa lafiya suna asibiti, kuma 995 (10%) sun mutu. Daga cikin marasa lafiya 160 da ke asibiti, 2 (995%) ko dai sun kamu da cutar asymptomatically ko kuma an kwantar da su a asibiti saboda dalilan da ba su da alaƙa da COVID-289. Matsakaicin shekarun marasa lafiyar da suka mutu shine shekaru 29. 19 (82%) na wadanda suka mutu ba su nuna alamun kamuwa da cuta ba ko kuma sun mutu sakamakon abubuwan da ba su da alaƙa da COVID-28, in ji rahoton.

  1. Likitan zuciya: rikitarwa na postcovid na iya zama mafi matsala fiye da cuta

A lokaci guda kuma, sun jaddada cewa a cikin mako guda na Afrilu 24-30, 355 aka yi rajista a yawan jama'a a Amurka. Yawan masu dauke da cutar covid19.

Takaitaccen bayani kan cututtukan cututtuka a cikin al'ummar da aka yi wa allurar tsawon watanni hudu cikakke (4 10 lokuta) da kamuwa da cuta a cikin dukkan jama'a daga mako guda kawai a ƙarshen Afrilu na wannan shekara (dubu 626) ya nuna cewa yana da daraja a yi masa allurar. , saboda haɗarin kamuwa da cutar coronavirus ta wanda aka yi wa allurar ya yi ƙasa sosai.

Marubutan sun yi nuni da cewa adadin masu kamuwa da cuta zai iya zama sama da wanda aka rubuta a cikin tsarin tattara bayanai kan cututtuka. An sani daga wasu binciken cewa matakin ƙwayar cuta ya ragu sosai a cikin mutanen da aka yi wa alurar riga kafi waɗanda duk da haka za su kamu da cutar. Don haka sau da yawa suna asymptomatic kuma ba su da yaduwa fiye da waɗanda ba a yi musu allurar ba (don haka ƙila ba za su san kamuwa da cutar ba kuma ƙila ba za su zo don gwaji ba).

  1. Jamus ta ba da shawarar hada alluran rigakafin COVID-19

Sauran binciken kuma sun nuna cewa kamuwa da cuta bayan alurar riga kafi yana da wuya.

Sakamakon daya daga cikinsu ya bayyana a watan Maris na wannan shekara a cikin mujallar "Rahoton Mako da Rage Mutuwa". Binciken ya duba tasirin rigakafin mRNA akan COVID-19 tsakanin ma'aikatan kiwon lafiya na Amurka, sabis na gaggawa da malamai, don haka waɗanda suka yi hulɗa da mutane da yawa kuma suna cikin haɗarin kamuwa da cutar ta coronavirus. Binciken ya shafi jimillar mutane kusan 4 daga jihohi takwas, wanda kashi 75 cikin dari. daga cikin waɗannan suna da aƙalla kashi ɗaya na rigakafin. Mafi yawa daga cikin waɗannan alluran rigakafin mRNA ne (kusan kashi 63% na waɗanda aka yiwa alurar riga kafi suna da maganin Pfizer, kuma kusan 30% - tare da Moderna).

Mahimmanci, duk mahalarta binciken an gwada su akai-akai mako-mako tare da gwaje-gwajen kwayoyin halitta, haka kuma, lokacin da akwai alamun kamuwa da cutar SARS-CoV-2, don haka ba zai yuwu a gano kamuwa da cutar ba, koda kuwa asymptomatic ne.

A cikin kusan mutane 4, yayin lura na watanni uku, an tabbatar da kamuwa da cutar SARS-CoV-2 a cikin 205 kawai. Daga cikin sassan da aka yi wa allurar rigakafi, watau waɗanda suka karɓi kashi ɗaya kawai na allurar a duk lokacin binciken ko kafin kashi na biyu, an tabbatar da kamuwa da cutar SARS-CoV-2 takwas. Duk cikinsu babu nauyi.

kamuwa da cutar bayan allurar rigakafi - wanene ya fi fuskantar haɗari?

– Alurar riga kafi kusan kashi 100 ne. an kare shi daga sake dawowa wani nau'i mai tsanani na cutar - ya tabbatar da prof. Ernest Kuchar, kwararre kan cututtuka, shugaban asibitin kula da lafiyar yara tare da Sashen Kulawa na Jami'ar Likita ta Warsaw.

  1. Laifukan COVID-19 sun karu a Turai. Menene dalilin Euro 2020?

A cewar kwararru, yana yiwuwa a yi hasashen wanda zai iya kasancewa a cikin wannan rukuni kuma ya kula da waɗannan mutane na musamman. Waɗannan su ne galibi marasa lafiya:

  1. tare da rage rigakafi da tsarin rigakafi mara inganci, gami da. mutanen da suka tsufa (binciken CDC ya nuna cewa mutanen da suka tsufa, sabili da haka sau da yawa ba su da rigakafi, suna da haɗarin haɓaka mai tsanani COVID-19), 
  2. mutanen da ke shan magungunan rigakafi, misali a cikin cututtukan rheumatological, oncological ko cututtukan dasawa.

“Alurar rigakafin COVID-19 muhimmin kayan aiki ne don shawo kan wannan annoba. Ƙaddamarwa daga tsawan lokacin wannan binciken yana ƙara shaida cewa rigakafin COVID-19 mRNA yana da tasiri kuma yakamata ya hana yawancin cututtuka. Mutanen da ke da cikakkiyar alurar riga kafi waɗanda suka kamu da COVID-19 suna iya samun mafi sauƙi, gajeriyar cuta kuma ba su da yuwuwar watsa kwayar cutar ga wasu mutane. Waɗannan fa'idodin wani muhimmin dalili ne na rigakafin, "in ji darektan CDC Rochelle P. Walensky.

  1. Manyan tambayoyi 15 game da kashi na biyu na maganin. Kwararrun sun amsa

Wasu binciken bincike sun nuna cewa cikakken ko wani bangare na allurar rigakafin da suka yi kwangilar COVID-19 na iya zama mai saukin kamuwa da kwayar cutar ga wasu mutane.

Don haka, saboda mummunan yanayin COVID-19, asibitoci a yau sun haɗa da mutanen da ba a yi musu allurar rigakafin cutar ba. Kowane rigakafin da ake samu a kasuwar EU yana rage haɗarin cutar COVID-19 mai tsanani.

CDC kuma ta lura cewa da yawan mutane suna yin rigakafin, yawan rigakafin zai yi tasiri. Alurar riga kafi yana hana yaduwar kwayar cutar, kuma kadan tana yawo a kusa da mu, karancin cututtuka, duka alamomi da ci gaba.

Kuna son gwada rigakafin COVID-19 bayan alurar riga kafi? Shin an kamu da cutar kuma kuna son bincika matakan rigakafin ku? Duba kunshin gwajin rigakafi na COVID-19, wanda zaku yi a wuraren cibiyar sadarwa na Diagnostics.

Ƙarshe masu ban sha'awa kuma sun zo daga Ƙasar Ingila, inda kashi 83,7 cikin dari. Ana yiwa balagaggu mazauna alurar riga kafi da aƙalla kashi ɗaya, da kashi 61,2. – cikakken. A ranar 27 ga Yuni, an yi rajista mafi yawan kamuwa da cuta tun daga 5 ga Fabrairu - sama da 18.

  1. Manyan tambayoyi 15 game da kashi na biyu na maganin. Kwararrun sun amsa

Adadin wadanda suka mutu, duk da cewa adadin wadanda suka mutu ya karu a baya-bayan nan, bai yi yawa ba. A Burtaniya, a halin yanzu ana samun mutuwar mutane da yawa zuwa ashirin a rana sakamakon COVID-19. Adadin asibitocin da aka kwantar saboda COVID-19 kuma ya kasance mai inganci, a ƙaramin matakin. Wannan yanayin ya sha bamban da na faɗuwar shekarar da ta gabata, lokacin da ɗaruruwan mutanen Burtaniya ke mutuwa daga COVID-19 kowace rana.

Monika Wysocka, Justyna Wojteczek, Zdrowie.pap.pl.

Karanta kuma:

  1. Yanzu zaku ɗauki kashi na biyu a kowane lokaci. Yadda za a yi?
  2. "Babban annoba ta Delta a cikin kasar da aka yi maganin alurar riga kafi"
  3. Menene ma'aurata ke buƙatar sani kafin su je allurar rigakafi?
  4. Manyan tambayoyi 15 game da kashi na biyu na maganin

Abubuwan da ke cikin gidan yanar gizon medTvoiLokony an yi niyya don haɓakawa, ba maye gurbin, tuntuɓar mai amfani da gidan yanar gizon da likitansu ba. An yi nufin gidan yanar gizon don dalilai na bayanai da ilimi kawai. Kafin bin ilimin ƙwararrun ƙwararrun, musamman shawarwarin likita, wanda ke ƙunshe a kan Yanar Gizonmu, dole ne ku nemi likita. Mai Gudanarwa ba ya ɗaukar kowane sakamako sakamakon amfani da bayanan da ke cikin gidan yanar gizon. Kuna buƙatar shawarwarin likita ko takardar sayan magani ta e-sikelin? Je zuwa halodoctor.pl, inda za ku sami taimakon kan layi - da sauri, cikin aminci kuma ba tare da barin gidanku ba.

Leave a Reply